{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T21:05:26Z","timestamp":1779829526817,"version":"3.53.1"},"reference-count":63,"publisher":"Begell House","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Crit Rev Immunol"],"published-print":{"date-parts":[[2026]]},"abstract":"<p>Phosphatidylinositol 4-kinase beta (PI4K&amp;beta;) is an essential lipid kinase in &lt;i&gt;Plasmodium&lt;\/i&gt; species, central to intracellular signaling, vesicular trafficking, and parasite development. Recent insights suggest PI4K&amp;beta; also plays a key role in modulating host immune responses. Through regulation of protein export, immune evasion mechanisms, and extracellular vesicle formation, PI4K&amp;beta; influences the immune landscape during malaria infection. Notably, inhibition of PI4K&amp;beta; disrupts parasite survival and may enhance immune recognition by impairing virulence factor trafficking and improving antigen presentation. Targeting PI4K&amp;beta; offers a promising dual-action strategy-direct antiplasmodial effects coupled with immunomodulation. This review explores PI4K&amp;beta;'s emerging role at the interface of parasite survival and host immunity, highlighting its therapeutic potential as both an antiparasitic and immunomodulatory target. Further investigation is warranted to evaluate its role in antigen processing, vaccine responsiveness, and combinatorial immunotherapy. PI4K&amp;beta; stands out as a next-generation target for integrated malaria intervention strategies.<\/p>","DOI":"10.1615\/critrevimmunol.2026061677","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T20:50:35Z","timestamp":1771966235000},"page":"27-43","source":"Crossref","is-referenced-by-count":0,"title":["Plasmodium Phosphatidylinositol 4-Kinase Beta (PI4K&amp;beta;): An Emerging Target at the Interface of Parasite Biology and Host Immunity"],"prefix":"10.1615","volume":"46","author":[{"given":"Vijaykumar D.","family":"Nimbarte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreya S.","family":"Sonak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirlipta","family":"Mohapatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharda","family":"Ishwarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swastik R.","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumith","family":"Mustajar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinisha","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. T.","family":"Sharanya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"613","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Oladipo HJ, Tajudeen YA, Oladunjoye IO, Yusuff SI, Yusuf RO, Oluwaseyi EM, AbdulBasit MO, Adebisi YA, El-Sherbini MS. Increasing challenges of malaria control in sub-Saharan Africa: Priorities for public health research and policymakers. Ann Med Surg. 2022;81:104366.","DOI":"10.1016\/j.amsu.2022.104366"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Eastman RT, Fidock DA. Artemisinin-based combination therapies: A vital tool in efforts to eliminate malaria. Nat Rev Microbiol. 2009;7:864-\u0080\u009374.","DOI":"10.1038\/nrmicro2239"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Venugopal K, Hentzschel F, Valki\u016bnas G, Marti M. Plasmodium asexual growth and sexual development in the haematopoietic niche of the host. Nat Rev Microbiol. 2020;18:177-\u0080\u009389.","DOI":"10.1038\/s41579-019-0306-2"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Kellermann M, Scharte F, Hensel M. Manipulation of host cell organelles by intracellular pathogens. Int J Mol Sci. 2021;22:6484.","DOI":"10.3390\/ijms22126484"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Batrouni AG, Baskin JM. The chemistry and biology of phosphatidylinositol 4-phosphate at the plasma membrane. Bioorg Med Chem. 2021;40:116190.","DOI":"10.1016\/j.bmc.2021.116190"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Elaagip A, Absalon S, Florentin A. Apicoplast dynamics during Plasmodium cell cycle. Front Cell Infect Microbiol. 2022;12:864819.","DOI":"10.3389\/fcimb.2022.864819"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Delang L, Paeshuyse J, Neyts J. The role of phosphatidylinositol 4-kinases and phosphatidylinositol 4-phosphate during viral replication. Biochem Pharmacol. 2012;84:1400-\u0080\u00938.","DOI":"10.1016\/j.bcp.2012.07.034"},{"key":"8","doi-asserted-by":"crossref","unstructured":"McNamara CW, Lee MCS, Lim CS, Lim SH, Roland J, Nagle A, Simon O, Yeung BKS, Chatterjee AK, Mc-Cormack SL, Manary MJ, Zeeman AM, Dechering KJ, Kumar TRS, Henrich PP, Gagaring K, Ibanez M, Kato N, Kuhen KL, Fischli C, Nakazawa Hewitt S, Winzeler EA, Llinas M, Fidock DA, Kappe SHI, Lange A, Ferla S, Brancale A, Leroy D, Wiesner J, Jomaa H. Targeting Plasmodium PI(4)K to eliminate malaria. Nature. 2013;504: 248-\u0080\u009353.","DOI":"10.1038\/nature12782"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Dinko B, Pradel G. Immune evasion by Plasmodium falciparum; parasites: Converting a host protection mechanism for the parasite's benefit. Adv Infect Dis. 2016;06:82-\u0080\u009395.","DOI":"10.4236\/aid.2016.62011"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Jensen AR, Adams Y, Hviid L. Cerebral Plasmodium falciparum malaria: The role of PfEMP1 in its pathogenesis and immunity, and PfEMP1-based vaccines to prevent it. Immunol Rev. 2020;293:230-\u0080\u009352.","DOI":"10.1111\/imr.12807"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Zhang F, Gaur NA, Hasek J, Kim Sj, Qiu H, Swanson MJ, Hinnebusch AG. Disrupting vesicular trafficking at the endosome attenuates transcriptional activation by Gcn4. Mol Cell Biol. 2008;28:6796-\u0080\u0093818.","DOI":"10.1128\/MCB.00800-08"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Vimonpatranon S, Roytrakul S, Phaonakrop N, Lekmanee K, Atipimonpat A, Srimark N, Sukapirom K, Chotivanich K, Khowawisetsut L, Pattanapanyasat K. Extracellular vesicles derived from early and late stage Plasmodium falciparum-infected red blood cells contain invasion-associated proteins. J Clin Med. 2022;11(14):4250.","DOI":"10.3390\/jcm11144250"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Sampaio NG, Cheng L, Eriksson EM. The role of extracellular vesicles in malaria biology and pathogenesis. Malar J. 2017;16:245.","DOI":"10.1186\/s12936-017-1891-z"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Lima T, Li TY, Mottis A, Auwerx J. Pleiotropic effects of mitochondria in aging. Nat Aging. 2022;2:199-\u0080\u0093213.","DOI":"10.1038\/s43587-022-00191-2"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Foko LPK, Narang G, Tamang S, Hawadak J, Jakhan J, Sharma A, Singh V. The spectrum of clinical biomarkers in severe malaria and new avenues for exploration. Virulence. 2022;13:634-\u0080\u009353.","DOI":"10.1080\/21505594.2022.2056966"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Arendse LB, Wyllie S, Chibale K, Gilbert IH. Plasmodium kinases as potential drug targets for malaria: Challenges and opportunities. ACS Infect Dis. 2021;7:518-\u0080\u009334.","DOI":"10.1021\/acsinfecdis.0c00724"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Ravi A, Palamiuc L, Emerling BM. Crucial players for inter-organelle communication: PI5P4Ks and their lipid product PI-4,5-P2 come to the surface. Front Cell Dev Biol. 2022;9:791758.","DOI":"10.3389\/fcell.2021.791758"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Van Der Boor SC, Van Gemert GJ, Hanssen AEJ, Van Waardenburg YM, McCall MBB, Bousema T, De Wilt JHW, Sauerwein RW, Yang ASP. Mid-liver stage arrest of Plasmodium falciparum schizonts in primary porcine hepatocytes. Front Cell Infect Microbiol. 2022;12: 834850.","DOI":"10.3389\/fcimb.2022.834850"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Ong HW, Adderley J, Tobin AB, Drewry DH, Doerig C. Parasite and host kinases as targets for antimalarials. Exp Opin Ther Targets. 2023;27:151-\u0080\u009369.","DOI":"10.1080\/14728222.2023.2185511"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Kiszewski AE. Blocking Plasmodium falciparum malaria transmission with drugs: The gametocytocidal and sporontocidal properties of current and prospective antimalarials. Pharmaceuticals. 2010;4:44-\u0080\u009368.","DOI":"10.3390\/ph4010044"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Dziwornu GA, Mmonwa MM, Coertzen D, Krugmann L, Salomane N, Leshabane M, Thomas J, Da Rocha S, Reader J, Masike K, Njoroge M, Sevilleno N, Lawrence N, Brunschwig C, De Kock C, Nchinda AT, Wiesner L, Gumede N, Bhatt TB, Hoppe HC, Chibale K. Novel inhibitors of Plasmodium phosphatidylinositol 4-kinase III\u00ce\u00b2 with low propensity for resistance: Life cycle stage activity and in vivo efficacy in a humanized mouse malaria infection model. J Med Chem. 2025;68:17736-\u0080\u009351.","DOI":"10.1021\/acs.jmedchem.5c01417"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Zeeman AM, Lakshminarayana SB, Van Der Werff N, Klooster EJ, Voorberg-van Der Wel A, Kondreddi RR, Bodenreider C, Simon O, Sauerwein R, Yeung BKS, Diagana TT, Kocken CHM. PI4 kinase is a prophylactic but not radical curative target in Plasmodium vivax-type malaria parasites. Antimicrob Agents Chemother. 2016;60:2858-\u0080\u009363.","DOI":"10.1128\/AAC.03080-15"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Tan VX, Guillemin GJ. Kynurenine pathway metabolites as biomarkers for amyotrophic lateral sclerosis. Front Neurosci. 2019;13:1013.","DOI":"10.3389\/fnins.2019.01013"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Frankland S, Adisa A, Horrocks P, Taraschi TF, Schneider T, Elliott SR, Rogerson SJ, Knuepfer E, Cowman AF, Newbold CI, Tilley L. Delivery of the malaria virulence protein PfEMP1 to the erythrocyte surface requires cholesterol-rich domains. Eukaryot Cell. 2006;5:849-\u0080\u009360.","DOI":"10.1128\/EC.5.5.849-860.2006"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Cabrera DG, Horatscheck A, Wilson CR, Basarab G, Eyermann CJ, Chibale K. Plasmodial kinase inhibitors: License to cure? J Med Chem. 2018;61:8061-\u0080\u009377.","DOI":"10.1021\/acs.jmedchem.8b00329"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Opadokun T, Agyapong J, Rohrbach P. Protein profiling of malaria-derived extracellular vesicles reveals distinct subtypes. Membranes. 2022;12:397.","DOI":"10.3390\/membranes12040397"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Dey S, Mohapatra S, Khokhar M, Hassan S, Pandey RK. Extracellular vesicles in malaria: Shedding light on pathogenic depths. ACS Infect Dis. 2024;10:827-\u0080\u009344.","DOI":"10.1021\/acsinfecdis.3c00649"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Kalkal M, Das J. Current understanding of the immune potential of B-cell subsets in malarial pathogenesis. Front Microbiol. 2023;14:1046002.","DOI":"10.3389\/fmicb.2023.1046002"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Pamplona A, Silva-Santos B. \u00ce\u00b3\u00ce\u00b4 T cells in malaria: A double-edged sword. FEBS J. 2021;288:1118-\u0080\u009329.","DOI":"10.1111\/febs.15494"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Mizuno-Yamasaki E, Medkova M, Coleman J, Novick P. Phosphatidylinositol 4-Phosphate controls both membrane recruitment and a regulatory switch of the Rab GEF Sec2p. Dev Cell. 2010;18:828-\u0080\u009340.","DOI":"10.1016\/j.devcel.2010.03.016"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Chan JA, Fowkes FJI, Beeson JG. Surface antigens of Plasmodium falciparum-infected erythrocytes as immune targets and malaria vaccine candidates. Cell Mol Life Sci. 2014;71:3633-\u0080\u009357.","DOI":"10.1007\/s00018-014-1614-3"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Wang H, Song H, Pham AV, Cooper LJ, Schulze JJ, Olek S, Tran DQ. Human LAP + GARP + FOXP3 + regulatory T cells attenuate xenogeneic graft versus host disease. Theranostics. 2019;9:2315-\u0080\u009324.","DOI":"10.7150\/thno.30254"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Maurya R, Tripathi A, Kumar M, Antil N, Yamaryo-Bott\u00e9 Y, Kumar P, Bansal P, Doerig C, Bott\u00e9 CY, Prasad TSK, Sharma P. PI4-kinase and PfCDPK7 signaling regulate phospholipid biosynthesis in Plasmodium falciparum. EMBO Rep. 2022;23:e54022.","DOI":"10.15252\/embr.202154022"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Sinden RE, Carter R, Drakeley C, Leroy D. The biology of sexual development of Plasmodium: The design and implementation of transmission-blocking strategies. Malar J. 2012;11:70.","DOI":"10.1186\/1475-2875-11-70"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Counihan NA, Chisholm SA, Bullen HE, Srivastava A, Sanders PR, Jonsdottir TK, Weiss GE, Ghosh S, Crabb BS, Creek DJ, Gilson PR, De Koning-Ward TF. Plasmodium falciparum parasites deploy RhopH2 into the host erythrocyte to obtain nutrients, grow and replicate. eLife. 2017;6:e23217.","DOI":"10.7554\/eLife.23217"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Pasternak ND, Dzikowski R. PfEMP1: An antigen that plays a key role in the pathogenicity and immune evasion of the malaria parasite Plasmodium falciparum. Int J Biochem Cell Biol. 2009;41:1463-\u0080\u00936.","DOI":"10.1016\/j.biocel.2008.12.012"},{"key":"37","doi-asserted-by":"crossref","unstructured":"Thangaraju K, Neerukonda SN, Katneni U, Buehler PW. Extracellular vesicles from red blood cells and their evolving roles in health, coagulopathy and therapy. Int J Mol Sci. 2020;22:153.","DOI":"10.3390\/ijms22010153"},{"key":"38","doi-asserted-by":"crossref","unstructured":"Salamanca DR, G\u00f3mez M, Camargo A, Cuy-Chaparro L, Molina-Franky J, Reyes C, Patarroyo MA, Patarroyo ME. Plasmodium falciparum blood stage antimalarial vaccines: An analysis of ongoing clinical trials and new perspectives related to synthetic vaccines. Front Microbiol. 2019;10:2712.","DOI":"10.3389\/fmicb.2019.02712"},{"key":"39","doi-asserted-by":"crossref","unstructured":"Bhattacharyya ND, Feng CG. Regulation of T helper cell fate by TCR signal strength. Front Immunol. 2020;11:624.","DOI":"10.3389\/fimmu.2020.00624"},{"key":"40","doi-asserted-by":"crossref","unstructured":"Yadav N, Parthiban C, Billman ZP, Stone BC, Watson FN, Zhou K, Olsen TM, Cruz Talavera I, Seilie AM, Kalata AC, Matsubara J, Shears MJ, Murphy SC, Wang R. More time to kill: A longer liver stage increases T cell-mediated protection against pre-erythrocytic malaria. iScience. 2023;26:108489.","DOI":"10.1016\/j.isci.2023.108489"},{"key":"41","doi-asserted-by":"crossref","unstructured":"Coffman RL, Sher A, Seder RA. Vaccine adjuvants: Putting innate immunity to work. Immunity. 2010;33:492-\u0080\u0093503.","DOI":"10.1016\/j.immuni.2010.10.002"},{"key":"42","doi-asserted-by":"crossref","unstructured":"Bruno PM, Timms RT, Abdelfattah NS, Leng Y, Lelis FJN, Wesemann DR, Yu XG, Elledge SJ. High-throughput, targeted MHC class I immunopeptidomics using a functional genetics screening platform. Nat Biotechnol. 2023;41:980-\u0080\u009392.","DOI":"10.1038\/s41587-022-01566-x"},{"key":"43","doi-asserted-by":"crossref","unstructured":"Leber W, Skippen A, Fivelman QL, Bowyer PW, Cockcroft S, Baker DA. A unique phosphatidylinositol 4-phosphate 5-kinase is activated by ADP-ribosylation factor in Plasmodium falciparum. Int J Parasitol. 2009;39:645-\u0080\u009353.","DOI":"10.1016\/j.ijpara.2008.11.015"},{"key":"44","doi-asserted-by":"crossref","unstructured":"Audhya A, Foti M, Emr SD. Distinct roles for the yeast phosphatidylinositol 4-kinases, Stt4p and Pik1p, in secretion, cell growth, and organelle membrane dynamics. Mol Biol Cell. 2000;11(8):2673-\u0080\u009389.","DOI":"10.1091\/mbc.11.8.2673"},{"key":"45","doi-asserted-by":"crossref","unstructured":"Waugh MG. The Great Escape: How phosphatidylinositol 4-kinases and PI4P promote vesicle exit from the Golgi (and drive cancer). Biochem J. 2019;476:2321-\u0080\u009346.","DOI":"10.1042\/BCJ20180622"},{"key":"46","doi-asserted-by":"crossref","unstructured":"Dongye Z, Li J, Wu Y. Toll-like receptor 9 agonists and combination therapies: Strategies to modulate the tumour immune microenvironment for systemic anti-tumour immunity. Br J Cancer. 2022;127:1584-\u0080\u009394.","DOI":"10.1038\/s41416-022-01876-6"},{"key":"47","doi-asserted-by":"crossref","unstructured":"Hallett RL, Sutherland CJ, Alexander N, Ord R, Jawara M, Drakeley CJ, Pinder M, Walraven G, Targett GAT, Alloueche A. Combination therapy counteracts the enhanced transmission of drug-resistant malaria parasites to mosquitoes. Antimicrob Agents Chemother. 2004;48:3940-\u0080\u00933.","DOI":"10.1128\/AAC.48.10.3940-3943.2004"},{"key":"48","doi-asserted-by":"crossref","unstructured":"Yang N, Ma P, Lang J, Zhang Y, Deng J, Ju X, Zhang G, Jiang C. Phosphatidylinositol 4-Kinase III\u00ce\u00b2 is required for severe acute respiratory syndrome coronavirus spike-mediated cell entry. J Biol Chem. 2012;287:8457-\u0080\u009367.","DOI":"10.1074\/jbc.M111.312561"},{"key":"49","doi-asserted-by":"crossref","unstructured":"Morrow AA, Alipour MA, Bridges D, Yao Z, Saltiel AR, Lee JM. The lipid kinase PI4KIII\u00ce\u00b2 is highly expressed in breast tumors and activates Akt in cooperation with Rab11a. Mol Cancer Res. 2014;12:1492-\u0080\u0093508.","DOI":"10.1158\/1541-7786.MCR-13-0604"},{"key":"50","doi-asserted-by":"crossref","unstructured":"Tan X, Banerjee P, Pham EA, Rutaganira FUN, Basu K, Bota-Rabassedas N, Guo HF, Grzeskowiak CL, Liu X, Yu J, Shi L, Peng DH, Rodriguez BL, Zhang J, Zheng V, Duose DY, Solis LM, Mino B, Raso MG, Behrens C, Wistuba II, Scott KL, Smith M, Nguyen K, Lam G, Choong I, Mazumdar A, Hill JL, Gibbons DL, Brown PH, Russell WK, Shokat K, Creighton CJ, Glenn JS, Kurie JM. PI4KIII\u00ce\u00b2 is a therapeutic target in chromosome 1q-amplified lung adenocarcinoma. Sci Transl Med. 2020;12: eaax3772.","DOI":"10.1126\/scitranslmed.aax3772"},{"key":"51","doi-asserted-by":"crossref","unstructured":"Miller TE, Henkels KM, Huddleston M, Salisbury R, Hussain SM, Sasaki AT, Cho KJ. Depletion of phosphatidylinositol 4-phosphate at the Golgi translocates K-Ras to mitochondria. J Cell Sci. 2019;132:jcs231886.","DOI":"10.1242\/jcs.231886"},{"key":"52","doi-asserted-by":"crossref","unstructured":"Shi L, Tan X, Liu X, Yu J, Bota-Rabassedas N, Niu Y, Luo J, Xi Y, Zong C, Creighton CJ, Glenn JS, Wang J, Kurie JM. Addiction to Golgi-resident PI4P synthesis in chromosome 1q21.3-\u0080\u0093amplified lung adenocarcinoma cells. Proc Natl Acad Sci U S A. 2021;118:e2023537118.","DOI":"10.1073\/pnas.2023537118"},{"key":"53","doi-asserted-by":"crossref","unstructured":"Wilson C, Venditti R, De Matteis MA. Deregulation of phosphatidylinositol-4-phosphate in the development of amyotrophic lateral sclerosis 8. Adv Biol Reg. 2021;79:100779.","DOI":"10.1016\/j.jbior.2020.100779"},{"key":"54","doi-asserted-by":"crossref","unstructured":"Sang Y, Niu C, Xu J, Zhu T, You S, Wang J, Zhang L, Du X, Zhang H. PI4KIII\u00ce\u00b2-mediated phosphoinositides metabolism regulates function of the VTA dopaminergic neurons and depression-like behavior. J Neurosci. 2024;44:e0555232024.","DOI":"10.1523\/JNEUROSCI.0555-23.2024"},{"key":"55","doi-asserted-by":"crossref","unstructured":"Ernest James Phillips T, Maguire E. Phosphoinositides: Roles in the development of microglial-mediated neuroinflammation and neurodegeneration. Front Cell Neurosci. 2021;15:652593.","DOI":"10.3389\/fncel.2021.652593"},{"key":"56","doi-asserted-by":"crossref","unstructured":"McNamara CW, Lee MC, Lim CS, Lim SH, Roland J, Nagle A, Simon O, Yeung BK, Chatterjee AK, McCormack SL, Manary MJ. Targeting Plasmodium PI (4) K to eliminate malaria. Nature. 2013;504(7479):248-\u0080\u009353.","DOI":"10.1038\/nature12782"},{"key":"57","unstructured":"Paquet T, Le Manach C, Cabrera DG, Younis Y, Henrich PP, Abraham TS, Lee MC, Basak R, Ghidelli-Disse S, Lafuente-Monasterio MJ, Bantscheff M. Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase. Sci Trans Med. 2017;9(387): eaad9735."},{"key":"58","doi-asserted-by":"crossref","unstructured":"Brunschwig C, Lawrence N, Taylor D, Abay E, Njoroge M, Basarab GS, Le Manach C, Paquet T, Cabrera DG, Nchinda AT, De Kock C. UCT943, a next-generation Plasmodium falciparum PI4K inhibitor preclinical candidate for the treatment of malaria. Antimicrob Agents Chemother. 2018;62(9):10-\u0080\u0093128.","DOI":"10.1128\/AAC.01941-18"},{"key":"59","doi-asserted-by":"crossref","unstructured":"Gibhard L, Njoroge M, Mulubwa M, Lawrence N, Smith D, Duffy J, Le Manach C, Brunschwig C, Taylor D, van der Westhuyzen R, Street LJ. Dose-fractionation studies of a Plasmodium phosphatidylinositol 4-kinase inhibitor in a humanized mouse model of malaria. Antimicrob Agents Chemother. 2024;68(10):e00842-\u0080\u009324.","DOI":"10.1128\/aac.00842-24"},{"key":"60","doi-asserted-by":"crossref","unstructured":"Sinxadi P, Donini C, Johnstone H, Langdon G, Wiesner L, Allen E, Duparc S, Chalon S, McCarthy JS, Lorch U, Chibale K. Safety, tolerability, pharmacokinetics, and antimalarial activity of the novel Plasmodium phosphatidylinositol 4-kinase inhibitor MMV390048 in healthy volunteers. Antimicrob Agents Chemother. 2020;64(4):10-\u0080\u0093128.","DOI":"10.1128\/AAC.01896-19"},{"key":"61","doi-asserted-by":"crossref","unstructured":"Mohammed R, Asres MS, Gudina EK, Adissu W, Johnstone H, Marrast AC, Donini C, Duparc S, Yilma D. Efficacy, safety, tolerability, and pharmacokinetics of MMV390048 in acute uncomplicated malaria. Am J Trop Med Hyg. 2022;108(1):81.","DOI":"10.4269\/ajtmh.22-0567"},{"key":"62","doi-asserted-by":"crossref","unstructured":"Arendse LB, Murithi JM, Qahash T, Pasaje CF, Godoy LC, Dey S, Gibhard L, Ghidelli-Disse S, Drewes G, Bantscheff M, Lafuente-Monasterio MJ. The anticancer human mTOR inhibitor sapanisertib potently inhibits multiple Plasmodium kinases and life cycle stages. Science Transl Med. 2022;14(667):eabo7219.","DOI":"10.1126\/scitranslmed.abo7219"},{"key":"63","doi-asserted-by":"crossref","unstructured":"Kato N, Comer E, Sakata-Kato T, Sharma A, Sharma M, Maetani M, Bastien J, Brancucci NM, Bittker JA, Corey V, Clarke D. Diversity-oriented synthesis yields novel multistage antimalarial inhibitors. Nature. 2016;538(7625):344-\u0080\u00939.","DOI":"10.1038\/nature19804"}],"container-title":["Critical Reviews in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dl.begellhouse.com\/download\/article\/7a324d561a700956\/CRI-61677.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T20:42:36Z","timestamp":1779828156000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dl.begellhouse.com\/journals\/2ff21abf44b19838,712794064b4c70af,7a324d561a700956.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1615\/critrevimmunol.2026061677","relation":{},"ISSN":["1040-8401"],"issn-type":[{"value":"1040-8401","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}